|
CNST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71451741692863E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5527136788005E-15 |
| Normal-vs-Stage2 |
7.06229519309431E-11 |
| Normal-vs-Stage3 |
5.81119999999435E-05 |
| Normal-vs-Stage4 |
1.326160E-02 |
| Stage1-vs-Stage2 |
8.793200E-01 |
| Stage1-vs-Stage3 |
3.634400E-02 |
| Stage1-vs-Stage4 |
2.744600E-01 |
| Stage2-vs-Stage3 |
6.863700E-02 |
| Stage2-vs-Stage4 |
3.801800E-01 |
| Stage3-vs-Stage4 |
8.187200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.04121180963557E-14 |
| Normal-vs-AfricanAmerican |
1.44020018133517E-10 |
| Normal-vs-Asian |
9.58679999999434E-05 |
| Caucasian-vs-AfricanAmerican |
7.842200E-01 |
| Caucasian-vs-Asian |
8.490200E-01 |
| AfricanAmerican-vs-Asian |
9.267400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.88578058618805E-15 |
| Normal-vs-Female |
6.86170000041564E-07 |
| Male-vs-Female |
3.143600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.92769999985654E-07 |
| Normal-vs-Extreme_Weight |
1.11022302462516E-15 |
| Normal-vs-Obese |
1.4520995517131E-10 |
| Normal-vs-Extreme_Obese |
1.79439999525854E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.315600E-01 |
| Normal_Weight-vs-Obese |
8.051800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.006400E-01 |
| Extreme_Weight-vs-Obese |
6.259900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.078200E-01 |
| Obese-vs-Extreme_Obese |
2.548800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.834800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.16020543067452E-11 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.93352017624693E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.409600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.539600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.835920E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.802500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.602300E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.830100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
8.43659586635681E-11 |
| Normal-VS-KIRP CIMP |
2.061200E-01 |
| Normal-VS-Unclassified PRCC |
5.974700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.825400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.53540000000475E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.064560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.825900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.203200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.766800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.30080004732281E-10 |
| Normal-vs-N1 |
8.658400E-03 |
| Normal-vs-N2 |
2.443900E-02 |
| N0-vs-N1 |
2.600500E-02 |
| N0-vs-N2 |
3.765600E-01 |
| N1-vs-N2 |
8.491600E-01 |
|
|
